Filter
478
Filtered Results: 478
Text search:
J.
Morris
Featured
Recommendations
41
New Publications
59
Language
Document type
No document type
215
Studies & Reports
127
Guidelines
89
Manuals
23
Strategic & Response Plan
10
Fact sheets
10
Training Material
2
Situation Updates
2
Countries / Regions
Global
23
Russia
16
Latin America and the Carribbean
15
India
13
Western and Central Europe
13
Brazil
9
Liberia
7
Kenya
7
South Africa
7
Nepal
6
Ukraine
6
Middle East and North Africa
6
Eastern Europe
6
Uganda
5
Rwanda
5
Eastern Europe and Central Asia
5
Africa
5
Germany
4
Mozambique
4
Ethiopia
3
Zimbabwe
3
South Sudan
3
Syria
3
Indonesia
3
Bangladesh
3
Yemen
3
West and Central Africa
3
South–East Asia Region
3
Sierra Leone
2
Nigeria
2
USA
2
Cameroon
2
Zambia
2
Malawi
2
Sudan
2
Lesotho
2
Mexico
2
Myanmar / Burma
2
East and Southern Africa
2
Asia
2
Venezuela
2
Vietnam
2
North America
2
Jamaica
2
Spain
2
Guinea
1
Burkina Faso
1
Congo, Democratic Republic of
1
Ghana
1
Haiti
1
Philippines
1
Pakistan
1
Afghanistan
1
Lebanon
1
Tanzania
1
China
1
Benin
1
Central African Republic
1
Argentina
1
Colombia
1
Botswana
1
Sri Lanka
1
Paraguay
1
Estonia
1
Kyrgyzstan
1
Uruguay
1
France
1
Authors & Publishers
Publication Years
Category
Countries
119
Clinical Guidelines
52
Public Health
36
Women & Child Health
28
Key Resources
13
Pharmacy & Technologies
3
Capacity Building
1
Toolboxes
COVID-19
83
Mental Health
77
Planetary Health
35
HIV
30
Disability
20
TB
19
NCDs
19
Caregiver
17
AMR
11
Rapid Response
8
NTDs
8
Refugee
7
Global Health Education
7
Ebola
6
Pharmacy
5
Health Financing Toolbox
5
Cholera
4
Zika
3
Conflict
2
Natural Hazards
1
Social Ethics
1
Health Financing
1
Nota INformatIva Nº 13/2020 - SE/GaB/SE/mS
September 2020
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
Key considerations for the use of law to prevent noncommunicable diseases in the WHO European Region
Report of an intensive legal training and capacity-building workshop on law and noncommunicable diseases (Moscow, 30 May–3 June 2016)
The report summarizes important issues, themes and topics discussed during the meeting in Moscow, ranging from the design and implementation of legislation, reconc...
23 décembre 2020 Ce document résume les recommandations de l'OMS concernant l'utilisation rationnelle des équipements de protection individuelle (EPI) dans les établissements de soins de santé et les stratégies temporaires en cas de pénurie aiguë d'approvisionnement. Ce document contient ég...
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es...
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
28 Jan. 2021. L’objet de ce document est de fournir des orientations provisoires sur la sécurité biologique en laboratoire applicable à l’analyse d’échantillons cliniques issus de patients.
It estimates that there have been 228,000 additional deaths of children under five in these six countries [Afghanistan, Nepal, Bangladesh, India, Pakistan and Sri Lanka] due to crucial services, ranging from nutrition benefits to immunisation, being halted.
It says the number of children being tr...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Orientations provisoires, 28 janvier 2021
Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de...
COVID-19 is a pandemic that is currently ravaging the world. Infection rate is steadily increasingin Sub-Saharan Africa. Pregnant women and their infants may suffer severe illnesses due to theirlower immunity. This guideline prepares and equips clinicians working in the maternal and new-born section...
COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa. The objectiveof this study was to document the perinatal outcomes of COVID-19 pregnancies and del...
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis...
This brief summarizes current evidence and guidance for maintaining safe and effective care across the spectrum of maternal, newborn and infant care while protecting mother and child and health care providers during COVID-19. Furthermore, implications of the principle of “do no harm” are reviewe...
The paper provides the rationale for these recommendations, which are based on analyses of data from the TRACT trial.
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
